撤稿：门冬胰岛素联合阿卡波糖与二甲双胍治疗糖尿病的临床疗效对比分析
Retracted: Comparative Analysis of Clinical Effects of Insulin Aspart Combined with Acarbose and Metformin in the Treatment of Diabetes Mellitus.
作者信息
And Alternative Medicine Evidence-Based Complementary
出版信息
Evid Based Complement Alternat Med. 2023 Jun 21;2023:9805178. doi: 10.1155/2023/9805178. eCollection 2023.
Abstract
[This retracts the article DOI: 10.1155/2022/3541931.].
摘要
[本文撤回文章DOI: 10.1155/2022/3541931。]
相似文献
1
Retracted: Comparative Analysis of Clinical Effects of Insulin Aspart Combined with Acarbose and Metformin in the Treatment of Diabetes Mellitus.撤稿：门冬胰岛素联合阿卡波糖与二甲双胍治疗糖尿病的临床疗效对比分析
Evid Based Complement Alternat Med. 2023 Jun 21;2023:9805178. doi: 10.1155/2023/9805178. eCollection 2023.
2
Comparative Analysis of Clinical Effects of Insulin Aspart Combined with Acarbose and Metformin in the Treatment of Diabetes Mellitus.门冬胰岛素联合阿卡波糖与二甲双胍治疗糖尿病的临床效果对比分析
Evid Based Complement Alternat Med. 2022 Jul 8;2022:3541931. doi: 10.1155/2022/3541931. eCollection 2022.
3
Comparative assessment of the efficacy and safety of acarbose and metformin combined with premixed insulin in patients with type 2 diabetes mellitus.阿卡波糖与二甲双胍联合预混胰岛素治疗2型糖尿病患者的疗效和安全性比较评估
Medicine (Baltimore). 2017 Sep;96(35):e7533. doi: 10.1097/MD.0000000000007533.
4
Retracted: Insulin Aspart Combined with Exercise Therapy in Spleen Deficiency Type Gestational Diabetes Mellitus: The Effect on Disease Control and Pregnancy Outcomes.撤回：门冬胰岛素联合运动疗法治疗脾虚型妊娠期糖尿病：对疾病控制及妊娠结局的影响
Evid Based Complement Alternat Med. 2023 Jul 12;2023:9862892. doi: 10.1155/2023/9862892. eCollection 2023.
5
The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. A multicenter controlled clinical trial.阿卡波糖治疗非胰岛素依赖型糖尿病患者的疗效。一项多中心对照临床试验。
Ann Intern Med. 1994 Dec 15;121(12):928-35. doi: 10.7326/0003-4819-121-12-199412150-00004.
6
Different Interactive Effects of Metformin and Acarbose With Dietary Macronutrient Intakes on Patients With Type 2 Diabetes Mellitus: Novel Findings From the MARCH Randomized Trial in China.二甲双胍和阿卡波糖与膳食常量营养素摄入量对2型糖尿病患者的不同交互作用：中国MARCH随机试验的新发现
Front Nutr. 2022 Apr 26;9:861750. doi: 10.3389/fnut.2022.861750. eCollection 2022.
7
Comparative efficacy and safety of two insulin aspart formulations (Rapilin and NovoRapid) when combined with metformin, for patients with diabetes mellitus: a multicenter, randomized, open-label, controlled clinical trial.两种门冬胰岛素制剂（来得时和诺和锐）联合二甲双胍治疗糖尿病患者的疗效和安全性比较：一项多中心、随机、开放标签、对照临床试验。
Curr Med Res Opin. 2022 Nov;38(11):1797-1806. doi: 10.1080/03007995.2022.2100652. Epub 2022 Jul 22.
8
Comparison of adjunctive therapy with metformin and acarbose in patients with Type-1 diabetes mellitus.1型糖尿病患者使用二甲双胍和阿卡波糖辅助治疗的比较。
Pak J Med Sci. 2017 May-Jun;33(3):686-690. doi: 10.12669/pjms.333.12669.
9
Effect of biphasic insulin aspart 30 combined with metformin on glycaemic control in obese people with type 2 diabetes.双相门冬胰岛素 30 联合二甲双胍对肥胖 2 型糖尿病患者血糖控制的影响。
Bosn J Basic Med Sci. 2007 Nov;7(4):335-8. doi: 10.17305/bjbms.2007.3023.
引用本文的文献
1
Effect of Initial Glucose Tolerance Test Response on Pregnancy Outcomes in Type A1 Gestational Diabetes.A1型妊娠期糖尿病患者初始葡萄糖耐量试验反应对妊娠结局的影响
Med Sci Monit. 2025 May 28;31:e947377. doi: 10.12659/MSM.947377.
本文引用的文献
1
Comparative Analysis of Clinical Effects of Insulin Aspart Combined with Acarbose and Metformin in the Treatment of Diabetes Mellitus.门冬胰岛素联合阿卡波糖与二甲双胍治疗糖尿病的临床效果对比分析
Evid Based Complement Alternat Med. 2022 Jul 8;2022:3541931. doi: 10.1155/2022/3541931. eCollection 2022.
Zotero 插件